Award of NHS National Generic Pharmaceuticals Framework for Clozapine

About

NHS England awarded a contract to Mylan, Britannia Pharmaceuticals, and Leyden Delta B.V.

for the supply of clozapine under the NHS National Generic Pharmaceuticals framework.

The framework agreement, reference CM/PHG/21/5634, had an initial period of call-offs from 1 August 2021 to 31 July 2023, with an option to extend for up to 24 months at the discretion of the Authority.

The contract value was AUD 17,670,738.